The Hemophagocytic Syndrome in an Immunocompromised Patient: A Diagnostic Challenge

I Fiteni; G Perez-Lungmus; JM Grasa; C Motis

doi:10.1155/2004/325836

The Hemophagocytic Syndrome in an Immunocompromised Patient: A Diagnostic Challenge

Canadian Journal of Infectious Diseases ◽

10.1155/2004/325836 ◽

2004 ◽

Vol 15 (2) ◽

pp. 101-103 ◽

Cited By ~ 2

Author(s):

I Fiteni ◽

G Perez-Lungmus ◽

JM Grasa ◽

C Motis

Keyword(s):

Hemophagocytic Syndrome ◽

Immunocompromised Patient ◽

Diagnostic Challenge

Download Full-text

PRIMARY CENTRAL NERVOUS SYSTEM EFFUSION PLASMABLASTIC LYMPHOMA IN IMMUNOCOMPROMISED PATIENT: A RARE PHENOMENON

Asian Journal of Pharmaceutical and Clinical Research ◽

10.22159/ajpcr.2018.v11i8.24754 ◽

2018 ◽

Vol 11 (8) ◽

pp. 6

Author(s):

Brij Mohan Singh ◽

Sushma Belurkar ◽

Arijit Bishnu ◽

Tanvi Shetty ◽

Pavithra P

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Immunocompromised Patient ◽

Primary Effusion Lymphoma ◽

High Rate ◽

Plasmablastic Lymphoma ◽

Diagnostic Challenge ◽

Aggressive Disease ◽

First Case ◽

Immunocompetent Patients

Primary effusion lymphoma (PEL) is an aggressive neoplasm with a high rate of fatality. PEL cells are known to have morphological diversities, which range from immunoblastic or plasmablastic to anaplastic. Most of these cases are described in immunocompromised as well as immunocompetent patients. Plasmablastic lymphoma remains a diagnostic challenge, especially when encountered with the presentation as PEL. In spite of therapeutic advances, PEL remains an aggressive disease with a high rate of fatality. We describe one case of this extremely rare neoplasm in an immunocompromised patient presenting in the form of primary central nervous system effusion plasmablastic lymphoma. To the best of our knowledge, this is the first case ever been reported in the literature.

Download Full-text

No fever, no malaria ? A diagnostic challenge in an immunocompromised patient

Travel Medicine and Infectious Disease ◽

10.1016/j.tmaid.2015.11.002 ◽

2015 ◽

Vol 13 (6) ◽

pp. 511-512 ◽

Cited By ~ 2

Author(s):

Sonja Gadient Hotz ◽

Dominic J. Müller ◽

Matthew Chaney ◽

Johannes Blum

Keyword(s):

Immunocompromised Patient ◽

Diagnostic Challenge

Download Full-text

Coinfection ofPneumocystis jiroveciiand Invasive Pulmonary Aspergillosis in an Immunocompromised Patient: A Diagnostic Challenge

Onkologie ◽

10.1159/000355168 ◽

2013 ◽

Vol 36 (10) ◽

pp. 582-584 ◽

Cited By ~ 2

Author(s):

Stefan Baumann ◽

Mark Reinwald ◽

Dariush Haghi ◽

Wolf-Karsten Hofmann ◽

Dieter Buchheidt

Keyword(s):

Immunocompromised Patient ◽

Invasive Pulmonary Aspergillosis ◽

Diagnostic Challenge ◽

Pulmonary Aspergillosis

Download Full-text

Disseminated Cutaneous Mycobacterium Haemophilum Infection and Concomitant Crusted Scabies in an Iatrogenically Immunocompromised Patient - A Case Report

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.2.10 ◽

2018 ◽

Vol 2 (2) ◽

pp. 150-154

Author(s):

Kristen Tessiatore ◽

Divya Sadhwani ◽

Kimberly Mancl ◽

Paul Rodriguez-Waitkus ◽

Lucia Seminario-Vidal

Keyword(s):

Case Report ◽

Rare Case ◽

Immunocompromised Patient ◽

Immunosuppressive Agents ◽

Immunosuppressed Patient ◽

Diagnostic Challenge ◽

Crusted Scabies ◽

Immunocompromised Hosts ◽

Mycobacterium Haemophilum ◽

Scabies Infestation

Mycobacterium haemophilum and crusted scabies are rare cutaneous diseases reported in distinct immunocompromised hosts. M. haemophilum is a skin and soft tissue infection, whereas crusted scabies is an infestation of the skin. Whereas scabies infestation is readily diagnosed, M. haemophilum infection poses a diagnostic challenge due to its rarity as well as varied clinical and histologic presentations. Although both scabies infestation and M. haemophilum have been reported in the literature separately, to our knowledge no previous reports have described these diseases occurring simultaneously in an iatrogenically immunosuppressed patient. We report herein a rare case of concomitant M. haemophilum and scabies infestation in a 38-year-old woman with dermatomyositis on multiple immunosuppressive agents.

Download Full-text